210 related articles for article (PubMed ID: 26928188)
1. Stability and degradation of fibroblast growth factor 23 (FGF23): the effect of time and temperature and assay type.
El-Maouche D; Dumitrescu CE; Andreopoulou P; Gafni RI; Brillante BA; Bhattacharyya N; Fedarko NS; Collins MT
Osteoporos Int; 2016 Jul; 27(7):2345-2353. PubMed ID: 26928188
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Storage Time and Repeated Freeze-Thaw Cycles on Intact Fibroblast Growth Factor 23 Levels.
Tang R; Lu Y; Yin R; Zhu P; Zhu L; Zheng C
Biopreserv Biobank; 2021 Feb; 19(1):48-52. PubMed ID: 33085535
[No Abstract] [Full Text] [Related]
3. Stability of Fibroblast Growth Factor 23 in Human Plasma.
Cui S; Vaingankar SM; Stenger A; Waikar SS; Leaf DE
J Appl Lab Med; 2017 May; 1(6):729-734. PubMed ID: 33379820
[TBL] [Abstract][Full Text] [Related]
4. Method-specific differences in plasma fibroblast growth factor 23 measurement using four commercial ELISAs.
Smith ER; McMahon LP; Holt SG
Clin Chem Lab Med; 2013 Oct; 51(10):1971-81. PubMed ID: 23729624
[TBL] [Abstract][Full Text] [Related]
5. Biological variability of plasma intact and C-terminal FGF23 measurements.
Smith ER; Cai MM; McMahon LP; Holt SG
J Clin Endocrinol Metab; 2012 Sep; 97(9):3357-65. PubMed ID: 22689697
[TBL] [Abstract][Full Text] [Related]
6. Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels.
Knab VM; Corbin B; Andrukhova O; Hum JM; Ni P; Rabadi S; Maeda A; White KE; Erben RG; Jüppner H; Christov M
Endocrinology; 2017 May; 158(5):1130-1139. PubMed ID: 28324013
[TBL] [Abstract][Full Text] [Related]
7. Intact fibroblast growth factor 23 and fragments in plasma from Gambian children.
Braithwaite V; Bruggraber SF; Prentice A
Osteoporos Int; 2013 Mar; 24(3):1121-4. PubMed ID: 22648001
[TBL] [Abstract][Full Text] [Related]
8. Technical and diagnostic performance of a new fully automated immunoassay for the determination of intact fibroblast growth factor 23 (FGF23).
van Helden J; Weiskirchen R
Scand J Clin Lab Invest; 2018; 78(7-8):584-590. PubMed ID: 30380963
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients.
Hanudel MR; Wesseling-Perry K; Gales B; Ramos G; Campbell V; Ethridge K; Scotti M; Elashoff DA; Alejos J; Reemtsen B; Salusky IB
Pediatr Nephrol; 2016 Apr; 31(4):661-9. PubMed ID: 26525200
[TBL] [Abstract][Full Text] [Related]
10. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
Wolf M; Koch TA; Bregman DB
J Bone Miner Res; 2013 Aug; 28(8):1793-803. PubMed ID: 23505057
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 23 is associated with the development of gestational diabetes mellitus.
Hocher CF; Chen X; Zuo J; Horvathova K; Hocher B; Krämer BK; Chu C
Diabetes Metab Res Rev; 2023 Nov; 39(8):e3704. PubMed ID: 37553983
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of FGF23 processing in fibrous dysplasia.
Bhattacharyya N; Wiench M; Dumitrescu C; Connolly BM; Bugge TH; Patel HV; Gafni RI; Cherman N; Cho M; Hager GL; Collins MT
J Bone Miner Res; 2012 May; 27(5):1132-41. PubMed ID: 22247037
[TBL] [Abstract][Full Text] [Related]
13. The effects of storage conditions on measurements of canine N-terminal pro-B-type natriuretic peptide.
Hezzell MJ; Boswood A; Lötter N; Elliott J
J Vet Cardiol; 2015 Mar; 17(1):34-41. PubMed ID: 25547663
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 23 and Klotho serum levels in healthy children.
Gkentzi D; Efthymiadou A; Kritikou D; Chrysis D
Bone; 2014 Sep; 66():8-14. PubMed ID: 24880094
[TBL] [Abstract][Full Text] [Related]
15. The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays.
Durham BH; Joseph F; Bailey LM; Fraser WD
Ann Clin Biochem; 2007 Sep; 44(Pt 5):463-6. PubMed ID: 17761032
[TBL] [Abstract][Full Text] [Related]
16. FGF23-S129F mutant bypasses ER/Golgi to the circulation of hyperphosphatemic familial tumoral calcinosis patients.
Shawar SM; Ramadan AR; Ali BR; Alghamdi MA; John A; Hudaib FM
Bone; 2016 Dec; 93():187-195. PubMed ID: 26620085
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 23 in acute burn patients: Novel insights from an intact-form assay.
Rousseau AF; Souberbielle JC; Delanaye P; Damas P; Cavalier E
Burns; 2016 Aug; 42(5):1082-1087. PubMed ID: 27215149
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly.
Chudek J; Kocełak P; Owczarek A; Bożentowicz-Wikarek M; Mossakowska M; Olszanecka-Glinianowicz M; Wiecek A
Nephrol Dial Transplant; 2014 Sep; 29(9):1757-63. PubMed ID: 24729016
[TBL] [Abstract][Full Text] [Related]
19. Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population?
Bożentowicz-Wikarek M; Kocełak P; Owczarek A; Olszanecka-Glinianowicz M; Mossakowska M; Skalska A; Więcek A; Chudek J
Clin Biochem; 2015 Apr; 48(6):431-6. PubMed ID: 25583093
[TBL] [Abstract][Full Text] [Related]
20. Effects of storage conditions on the stability of serum CD163, NGAL, HMGB1 and MIP2.
Wang J; Zhu HH; Xue JH; Wu SS; Chen Z
Int J Clin Exp Pathol; 2015; 8(4):4099-105. PubMed ID: 26097598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
